Literature DB >> 10349846

The endogenous lipid oleamide activates serotonin 5-HT7 neurons in mouse thalamus and hypothalamus.

E A Thomas1, B F Cravatt, J G Sutcliffe.   

Abstract

Oleamide is an endogenous lipid that accumulates during sleep deprivation and has hypothermic effects when administered to rodents. The mechanisms for its activity remain unknown. Intraperitoneal injections of oleamide elicited dramatic increases in content of c-fos mRNA and Fos protein in distinct brain regions, including cingulate and somatosensory cortical areas and numerous nuclei of the thalamus and hypothalamus, indicating that there are explicit targets for its action. In the thalamus and hypothalamus a majority of neurons induced for c-fos expression also expressed the serotonin 5-HT7 receptor, an allosteric target for oleamide in in vitro studies. These data suggest that oleamide may act at 5-HT7 receptors to elicit alterations in transcription that result in some of its physiological effects.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10349846     DOI: 10.1046/j.1471-4159.1999.0722370.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

1.  Potent and selective alpha-ketoheterocycle-based inhibitors of the anandamide and oleamide catabolizing enzyme, fatty acid amide hydrolase.

Authors:  F Anthony Romero; Wu Du; Inkyu Hwang; Thomas J Rayl; F Scott Kimball; Donmienne Leung; Heather S Hoover; Richard L Apodaca; J Guy Breitenbucher; Benjamin F Cravatt; Dale L Boger
Journal:  J Med Chem       Date:  2007-02-06       Impact factor: 7.446

2.  Exceptionally potent inhibitors of fatty acid amide hydrolase: the enzyme responsible for degradation of endogenous oleamide and anandamide.

Authors:  D L Boger; H Sato; A E Lerner; M P Hedrick; R A Fecik; H Miyauchi; G D Wilkie; B J Austin; M P Patricelli; B F Cravatt
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 3.  Fatty acid amide signaling molecules.

Authors:  Cyrine Ezzili; Katerina Otrubova; Dale L Boger
Journal:  Bioorg Med Chem Lett       Date:  2010-08-13       Impact factor: 2.823

Review 4.  The endocannabinoid system as an emerging target of pharmacotherapy.

Authors:  Pál Pacher; Sándor Bátkai; George Kunos
Journal:  Pharmacol Rev       Date:  2006-09       Impact factor: 25.468

5.  Structure-activity relationships of alpha-ketooxazole inhibitors of fatty acid amide hydrolase.

Authors:  Christophe Hardouin; Michael J Kelso; F Anthony Romero; Thomas J Rayl; Donmienne Leung; Inkyu Hwang; Benjamin F Cravatt; Dale L Boger
Journal:  J Med Chem       Date:  2007-06-09       Impact factor: 7.446

6.  Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors.

Authors:  James D Leggett; S Aspley; S R G Beckett; A M D'Antona; D A Kendall; D A Kendall
Journal:  Br J Pharmacol       Date:  2004-01-05       Impact factor: 8.739

7.  No hypothermic response to serotonin in 5-HT7 receptor knockout mice.

Authors:  P B Hedlund; P E Danielson; E A Thomas; K Slanina; M J Carson; J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-15       Impact factor: 11.205

8.  Passiflora incarnata attenuation of neuropathic allodynia and vulvodynia apropos GABA-ergic and opioidergic antinociceptive and behavioural mechanisms.

Authors:  Urooj Aman; Fazal Subhan; Muhammad Shahid; Shehla Akbar; Nisar Ahmad; Gowhar Ali; Khwaja Fawad; Robert D E Sewell
Journal:  BMC Complement Altern Med       Date:  2016-02-24       Impact factor: 3.659

9.  Multidimensional Liquid Chromatography Coupled with Tandem Mass Spectrometry for Identification of Bioactive Fatty Acyl Derivatives.

Authors:  Erin B Divito; Kristin M Kroniser; Michael Cascio
Journal:  Front Physiol       Date:  2016-12-15       Impact factor: 4.566

10.  Acute 5-HT7 receptor activation increases NMDA-evoked currents and differentially alters NMDA receptor subunit phosphorylation and trafficking in hippocampal neurons.

Authors:  Maryam S Vasefi; Kai Yang; Jerry Li; Jeff S Kruk; John J Heikkila; Michael F Jackson; John F MacDonald; Michael A Beazely
Journal:  Mol Brain       Date:  2013-05-14       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.